Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Oliver Blank"'
Publikováno v:
IEEE Transactions on Electron Devices. 70:1168-1175
Publikováno v:
Applied Physics Letters. 121:062107
We present characterization results of integrated vacuum gaps in semiconductors and report the highest breakdown field of dielectric layers ever recorded within microfabricated semiconductor devices. Difficulties associated with the characterization
Publikováno v:
Microelectronic Engineering. 264:111870
Autor:
Stefan Karner, Oliver Blank, Maximilian Rösch, Manfred Burghammer, Jakub Zalesak, Jozef Keckes, Juraj Todt
Publikováno v:
Materialia. 24:101484
Publikováno v:
2020 32nd International Symposium on Power Semiconductor Devices and ICs (ISPSD).
The interaction between the reverse recovery charge and the output charge in trench power MOSFETs is discussed. As the trade-off between the on-resistance and the gate charge improves, the output capacitance has more impact on the reverse recovery lo
Design considerations for charge‐compensated fast‐switching power MOSFET in the medium‐voltage range
Publikováno v:
IET Power Electronics. 11:638-645
Low-voltage power metal-oxide-semiconductor field-effect transistors (MOSFETs) based on charge compensation using a field plate offer a significant reduction of the area-specific on-resistance. The extension of their blocking capability into the so-c
Autor:
Michael Hutzler, Ralf Siemieniec, Oliver Blank, David Laforet, Li Juin Yip, Alan Huang, Ralf Walter
Publikováno v:
Facta universitatis - series: Electronics and Energetics. 28:477-494
Low-voltage power MOSFETs based on charge-compensation using a field-plate offer a significant reduction of the area-specific on-resistance. Beside a further improvement of this key parameter, the new device generation takes an in-depth focus on the
Publikováno v:
The Cochrane Library
Background Combined modality treatment consisting of chemotherapy followed by localised radiotherapy is the standard treatment for patients with early stage Hodgkin lymphoma (HL). However, due to long- term adverse effects such as secondary malignanc
Publikováno v:
The Cochrane Library
Reason for Withdrawal Authors have made no progress with this protocol in several years. New authors are being sought to take over this protocol. To view the published versions of this article, please click the 'Other versions' tab.
Autor:
Oliver Blank, Jörg-Janne Vehreschild, Ina Monsef, Nicole Skoetz, Julia Bohlius, Andreas Engert
Publikováno v:
The Cochrane Library
Skoetz, Nicole; Bohlius, Julia; Engert, Andreas; Monsef, Ina; Blank, Oliver; Vehreschild, Jörg-Janne (2015). Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy. Cochrane database of systematic reviews, 12(12), CD007107. WileyInterscience 10.1002/14651858.CD007107.pub3
Skoetz, Nicole; Bohlius, Julia; Engert, Andreas; Monsef, Ina; Blank, Oliver; Vehreschild, Jörg-Janne (2015). Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy. Cochrane database of systematic reviews, 12(12), CD007107. WileyInterscience 10.1002/14651858.CD007107.pub3
BACKGROUND Febrile neutropenia (FN) and other infectious complications are some of the most serious treatment-related toxicities of chemotherapy for cancer, with a mortality rate of 2% to 21%. The two main types of prophylactic regimens are granulocy